ARMK
Aramark37.65
+0.03+0.08%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q1 '26
Reaffirms growth; AI, healthcare nuggets.
Q&A largely reaffirms prepared remarks on robust new wins like RWJBarnabas and record retention, but highlights clients' strategic shift to consolidated healthcare platforms for cost synergies. Management eyes exceeding 4%-5% net new amid normalized bidding and quantifies FY pricing at 3%, volumes 0.5%-1%. AI delivers supply chain gains now with minimal spend; they view it as growth opportunity, not threat, including data centers. Cash burn rose from new business CapEx, normalizing soon. Retention stays hyper-focused. Momentum rolls on.
Key Stats
Market Cap
9.90BP/E (TTM)
30.86Basic EPS (TTM)
1.22Dividend Yield
0.01%Recent Filings
8-K
Aramark grants COOs $3M RSUs
Aramark's Compensation Committee approved $3M RSU grants on February 17, 2026, to COO Marc Bruno (U.S. Food and Facilities) and COO Carl Mittleman (International), effective February 19. Vesting hits on the third anniversary or six months post-permanent CEO successor start, whichever first. Retention locked in. Accelerated vesting ties to qualifying terminations.
8-K
Q1 revenue up 6% despite shift
Aramark posted Q1 fiscal 2026 revenue of $4.8B, up 6% year-over-year, with organic growth at 5%; Adjusted Operating Income rose 1% to $263M despite a calendar shift dragging results. Strong client retention and new wins outpace full-year net new business targets. Repurchased $30M in stock; repriced $2.4B term loans, saving 25bps. Fiscal 2026 outlook targets 7-9% revenue growth, 20-25% Adjusted EPS growth. Momentum builds.
10-Q
Q1 FY2026 results
Aramark posted revenue up 6.1% y/y to $4.8B for Q1 FY2026 ended January 2, 2026, fueled by FSS United States growth in Business & Industry (+18.1%) and FSS International surge (+17.4%, aided by 4.1% FX tailwind), yet operating income held flat at $217.5M amid calendar shift headwinds and higher personnel costs. Diluted EPS dipped to $0.36 from $0.39 on elevated interest expense, reconciling cleanly to 266.3M shares. Cash fell to $439.6M with $782.2M operating outflow, offset by $625M Receivables Facility draw; total debt climbed to $6.2B but revolver boasts $936.2M availability. Small acquisitions added $33M; share repurchases hit $41M. Solid international momentum persists. Competition in contract renewals looms.
8-K
Shareholders back board, auditors
8-K
Aramark reprices $2.38B term debt
Aramark refinanced its $2.38B U.S. Term B-8 Loans with new U.S. Term B-10 Loans on December 11, 2025, extending maturity to June 2030 while cutting the SOFR margin to 1.75% from 2.00%. Lenders rolled over $2.15B cashlessly; JPMorgan funded the $236M balance. Quarterly amortization kicks in December 2028.
IPO
Website
Employees
Sector
Industry
ABM
ABM Industries Incorporated
45.74-1.44
ADMQ
ADM Endeavors Inc.
0.05-0.00
ARKO
ARKO Corp.
5.05+0.04
ARKR
Ark Restaurants Corp.
6.63-0.23
CHEF
The Chefs' Warehouse, Inc.
63.33+0.04
HCSG
Healthcare Services Group, Inc.
19.09-0.27
NUTX
Nutex Health Inc.
171.72-4.06
PC
Premium Catering (Holdings) Lim
9.40+0.00
SYY
Sysco Corporation
75.12-0.31
WFCF
Where Food Comes From, Inc.
11.93-0.90